A reverse convertible note (RCN) offers high yields but comes with significant risks. Learn how this short-term investment, ...

Compass, Inc. (NYSE: COMP) (the "Company"), today announced the pricing of its offering of $850.0 million in aggregate principal amount of convertible senior notes due 2031 (the "Notes") in a private ...

Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

Compass, Inc. (NYSE: COMP) (the "Company") announces that it intends to offer (the "Offering"), subject to market and other conditions, $750.0 million in aggregate principal amount of convertible ...

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Markets have a habit of ignoring infrastructure until it becomes unavoidable. That pattern is repeating in sustainability, compliance, and global ...

The latest update is out from ETHZilla Corporation ( (ETHZ)). On December 16, 2025, ETHZilla Corporation held a special meeting where stockholders representing 79.8% of voting shares were present. The ...

Substantially All of Net Proceeds Expected to Be Used to Repurchase Approximately $1.6 Billion of Common Stock and for Capped Call Transactions Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) ...

- Investment to Fund Phase 1 Study in Renal Allograft Antibody-Mediated Rejection (AMR) in China SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 11, 2025 / CASI Pharmaceuticals, Inc.

CoreWeave plans a $2 billion convertible note offering as it scales AI infrastructure, following a yearlong pursuit of Core Scientific for added power capacity. AI infrastructure provider CoreWeave ...

Fastly, Inc. (NYSE: FSLY) today announced its intention to offer, subject to market and other conditions, $125.0 million aggregate principal amount of convertible senior notes due 2030 (the “notes”) ...